The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD ; volume:15 ; number:1 ; day:21 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (21.7.2024), 1-18, 12.2024
- Urheber
-
Ghosh, Sayan
Sharma, Ruchi
Bammidi, Sridhar
Koontz, Victoria
Nemani, Mihir
Yazdankhah, Meysam
Kedziora, Katarzyna M.
Stolz, Donna Beer
Wallace, Callen T.
Yu-Wei, Cheng
Franks, Jonathan
Bose, Devika
Shang, Peng
Ambrosino, Helena M.
Dutton, James R.
Geng, Zhaohui
Montford, Jair
Ryu, Jiwon
Rajasundaram, Dhivyaa
Hose, Stacey
Sahel, José-Alain
Puertollano, Rosa
Finkel, Toren
Zigler, J. Samuel
Sergeev, Yuri
Watkins, Simon C.
Goetzman, Eric S.
Ferrington, Deborah A.
Flores-Bellver, Miguel
Kaarniranta, Kai
Sodhi, Akrit
Bharti, Kapil
Handa, James T.
Sinha, Debasish
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50500-z
- URN
-
urn:nbn:de:101:1-2410250910089.499040944456
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghosh, Sayan
- Sharma, Ruchi
- Bammidi, Sridhar
- Koontz, Victoria
- Nemani, Mihir
- Yazdankhah, Meysam
- Kedziora, Katarzyna M.
- Stolz, Donna Beer
- Wallace, Callen T.
- Yu-Wei, Cheng
- Franks, Jonathan
- Bose, Devika
- Shang, Peng
- Ambrosino, Helena M.
- Dutton, James R.
- Geng, Zhaohui
- Montford, Jair
- Ryu, Jiwon
- Rajasundaram, Dhivyaa
- Hose, Stacey
- Sahel, José-Alain
- Puertollano, Rosa
- Finkel, Toren
- Zigler, J. Samuel
- Sergeev, Yuri
- Watkins, Simon C.
- Goetzman, Eric S.
- Ferrington, Deborah A.
- Flores-Bellver, Miguel
- Kaarniranta, Kai
- Sodhi, Akrit
- Bharti, Kapil
- Handa, James T.
- Sinha, Debasish
- SpringerLink (Online service)
Ähnliche Objekte (12)
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Gains in the current understanding of managing neovascular AMD with brolucizumab
Cataract surgery in neovascular AMD: impact on visual acuity and disease activity
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Purinergic signalling pathway: therapeutic target in ovarian cancer
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Therapeutic intervention in neuroinflammation for neovascular ocular diseases through targeting the cGAS-STING-necroptosis pathway